Moll T S, Harms A C, Elfarra A A
Department of Comparative Biosciences, University of Wisconsin Biotechnology Center, University of Wisconsin, Madison, Wisconsin 53706-1102, USA.
Chem Res Toxicol. 2000 Nov;13(11):1103-13. doi: 10.1021/tx000151f.
A widely used method for assessing occupational and environmental exposure to 1,3-butadiene involves the detection of hemoglobin adducts formed by the reactive metabolite butadiene monoxide (BMO). This assay employs the N-alkyl Edman method, which was developed to determine adducts formed at the amine group of the N-terminal valine of hemoglobin. Disadvantages of this procedure include its limitation to detecting only one adduct per globin chain, despite the presence of numerous other, and potentially more reactive, nucleophilic amino acids in hemoglobin. The method is also not suitable for determining whether the reaction of BMO occurs at the N-terminal valine of alpha- or beta-globin. The primary goals of the current research are to determine the degree of modification of alpha- and beta-globin chains by BMO and to localize the reactive residues to specific regions of the globin polypeptides. The reaction products after in vitro incubation of C57Bl/6 mouse erythrocytes with BMO were isolated by acid extraction of heme and microprecipitation of globin, followed by the determination of the number and location of adducts by mass spectrometry. The modification degree was monitored by electrospray mass spectrometry, which was used to measure the time- and concentration-dependent formation of BMO-hemoglobin adducts (< or =10 adducts per globin). The results indicate that BMO reacts faster and to a higher degree with alpha-globin than with beta-globin. Structural analysis was performed by peptide mapping of globin peptides after trypsin digestion using liquid chromatography/mass spectrometry. These experiments allowed the localization of BMO-hemoglobin adducts to specific regions within alpha- and beta-globin, and also provided information about their relative reactivity. Interestingly, the initial site of adduct formation on alpha-globin is located near the N-terminal peptide, whereas the initial site on beta-globin is located at the C-terminal region. Collectively, the results establish differences in the reactivities of alpha- and beta-globin toward BMO, demonstrate the formation of multiple adducts at several alpha- and beta-globin sites, and show that the N-terminal valine residues are not the first to be modified by BMO.
一种广泛用于评估职业和环境中1,3 - 丁二烯暴露情况的方法,涉及检测由活性代谢物丁二烯 monoxide(BMO)形成的血红蛋白加合物。该检测采用N - 烷基埃德曼法,此方法是为测定在血红蛋白N端缬氨酸的胺基处形成的加合物而开发的。该程序的缺点包括,尽管血红蛋白中存在许多其他可能更具反应性的亲核氨基酸,但它仅限于每条珠蛋白链仅检测一种加合物。该方法也不适用于确定BMO的反应是否发生在α - 或β - 珠蛋白的N端缬氨酸处。当前研究的主要目标是确定BMO对α - 和β - 珠蛋白链的修饰程度,并将反应性残基定位到珠蛋白多肽的特定区域。将C57Bl/6小鼠红细胞与BMO进行体外孵育后,通过血红素的酸提取和珠蛋白的微沉淀来分离反应产物,随后通过质谱法测定加合物的数量和位置。通过电喷雾质谱监测修饰程度,该质谱用于测量BMO - 血红蛋白加合物的时间和浓度依赖性形成(每条珠蛋白≤10个加合物)。结果表明,BMO与α - 珠蛋白的反应比与β - 珠蛋白更快且程度更高。使用液相色谱/质谱对胰蛋白酶消化后的珠蛋白肽段进行肽图分析,从而进行结构分析。这些实验使BMO - 血红蛋白加合物能够定位到α - 和β - 珠蛋白内的特定区域,同时也提供了有关它们相对反应性的信息。有趣的是,α - 珠蛋白上加合物形成的初始位点位于靠近N端肽段处,而β - 珠蛋白上的初始位点位于C端区域。总体而言,这些结果确定了α - 和β - 珠蛋白对BMO反应性的差异,证明了在几个α - 和β - 珠蛋白位点形成了多个加合物,并表明N端缬氨酸残基不是首先被BMO修饰的。